European Companies Search Engine
14 wordmarks: BEZYNVI, EPZYNVO, EVIGUS, IPSYNVO, MARKLAS, NOILETCAPHARM, NUFLOZIA, OMLUENNE, OPAIRVI, OPZIPULM, PAHDUA, PERCUREX, TAVLEED, ZUXTANA BdlYear 2022 European Union Intellectual Property Office (Trade Marks)
Text
Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
| 17/08/2022 | Wordmark: “BEZYNVI“ |
| 17/08/2022 | Wordmark: “EPZYNVO“ |
| 15/04/2022 | Wordmark: “EVIGUS“ |
| 17/08/2022 | Wordmark: “IPSYNVO“ |
| 28/07/2022 | Wordmark: “MARKLAS“ |
| 28/07/2022 | Wordmark: “NOILETCAPHARM“ |
| 15/04/2022 | Wordmark: “NUFLOZIA“ |
| 17/08/2022 | Wordmark: “OMLUENNE“ |
| 17/08/2022 | Wordmark: “OPAIRVI“ |
| 17/08/2022 | Wordmark: “OPZIPULM“ |
| 28/06/2022 | Wordmark: “PAHDUA“ |
| 28/07/2022 | Wordmark: “PERCUREX“ |
| 22/03/2022 | Wordmark: “TAVLEED“ |
| 22/03/2022 | Wordmark: “ZUXTANA“ |
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.
The visualizations for "Actelion Pharmaceuticals Ltd. - 14 wordmarks: BEZYNVI, EPZYNVO, EVIGUS, IPSYNVO, MARKLAS, NOILETCAPHARM, NUFLOZIA, OMLUENNE, OPAIRVI, OPZIPULM, PAHDUA, PERCUREX, TAVLEED, ZUXTANA"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.